InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,299.20
(
0.01%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.34%
)
Bitcoin
63,460.77
(
-0.25%
)
Post# of 13962
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

baulsdp

Send PM Follow Ignore
Followers 39
Posts 4232
Boards Moderated 0
Alias Born 02/23/2012

baulsdp

Re: None

Thursday, 10/20/2016 11:51:37 AM

Thursday, October 20, 2016 11:51:37 AM

Post# of 13962
We all(longs) know the price per share is going to rocket. 7 clinical trial canidates in the pipeline is insane. If 1 hits the market it's a new game if only 29% of them hit the market it's going to $5 over night. That's only 2 of 7 and 1 is halfway there being in EU. I think it's a good bet that we get to market in the US with Ceplene. That is what I see coming next, maybe TODAY! So that's 1. Amiket is ready to hit Phase III. Mid year 2017 could hit the market. That's 2 & $5-$10 over night.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up